# Pramipexole Dihydrochloride Extended-Release

NDC: 69680-145
Generic name: Pramipexole Dihydrochloride
Labeler / Manufacturer: Vitruvias Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20210827

FDA application: ANDA212797

## Active ingredients

- PRAMIPEXOLE DIHYDROCHLORIDE: .375 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69680-145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69680-145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d07aad1b-e078-4fca-8386-ca2e8e899688